Literature DB >> 1662833

Arylamine spider toxins antagonize NMDA receptor-mediated synaptic transmission in rat hippocampal slices.

A L Mueller1, B C Albensi, A H Ganong, L S Reynolds, H Jackson.   

Abstract

The effects of arylamine spider toxins on synaptic transmission in rat hippocampal slices were investigated. Two different responses were monitored: the AMPA receptor-mediated population spike recorded in control buffer (selectively antagonized by DNQX) and the NMDA receptor-mediated EPSP recorded in nominally magnesium-free buffer containing 20 microM DNQX (selectively antagonized by AP5, AP7, and dizocilpine (MK-801)). The synthetic arylamine spider toxins JSTX-3, argiotoxin-636, and argiotoxin-659 were 26 to 73 times more potent at antagonizing the NMDA receptor-mediated EPSP (IC50 values ranging from 12 to 24 microM) than the AMPA receptor-mediated population spike (IC50 values ranging from 612 to 878 microM). These results indicate that arylamine spider toxins are selective antagonists of NMDA receptors in the mammalian CNS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662833     DOI: 10.1002/syn.890090403

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  3 in total

1.  Distinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress.

Authors:  Zoé A McElligott; Jason R Klug; William P Nobis; Sachin Patel; Brad A Grueter; Thomas L Kash; Danny G Winder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

2.  Design, synthesis, and biological evaluation of spider toxin (argiotoxin-636) analogs as NMDA receptor antagonists.

Authors:  S T Moe; D L Smith; Y Chien; J L Raszkiewicz; L D Artman; A L Mueller
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

Review 3.  Spider Neurotoxins as Modulators of NMDA Receptor Signaling.

Authors:  Artur Pałasz; Marek Krzystanek
Journal:  Neuromolecular Med       Date:  2021-09-25       Impact factor: 4.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.